Clinical Trials

Quality Improvement Strategies to Optimize Outpatient Step-Up Dosing for Elranatamab in Relapsed/Refractory Multiple Myeloma

Online First

North American Enrollment in Clinical Trials: An Emerging Issue for Regulatory Approval

Ming-Hei Tai, PharmD, BCOP

Pirtobrutinib in Covalent BTKi-Treated Patients With CLL/SLL: Translating Clinical Trial Insights Into Real-World Practice

AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small Cell Lung Cancer

The Evolution of Abemaciclib Clinical Trial Data for the Treatment of HR-Positive/HER2-Negative Metastatic Breast Cancer

Identification and Treatment of Patients With Hormone Receptor–Positive, HER2-Negative Early Breast Cancer at High Risk of Recurrence: monarchE Study Long-Term Outcomes

Pirtobrutinib in Pretreated Patients With CLL/SLL: Applying Lessons From Clinical Trials to Clinical Practice

Defining Value in a Nontraditional Investigational Drug Service Pharmacy Model

Molly Schmidt, PharmD, BCPS, BCOP, CSP; Robin Lockhorst, PharmD, BCPS, BCOP; Grant Middendorff, PharmD; Tiffani R. Kirkpatrick, PharmD

Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy Activities

Nicholas A. Vitanza, MD; Michelle Choe, MD; Christopher Brown, BA; Adam Beebe, BA; Ada Kong, PharmD; Lisa Rogers, PharmD, et al.

Pancreatic Cancer: Review of the Current and Investigational Drug Landscape

Kevin H. Pang, PharmD; Valassia Antigone Theocharides; Yuxi Lei; Shivani K. Rana, BS; Richa K. Rana, BS; Mark H. Mansour; Meghana K. Ganjam; Jennifer Ahmed, PharmD

Page 1 of 2
Results 1 - 10 of 18

Clinical Trials

Subscribe Today!

I'd like to receive: